Treatment Indications: correction of deep facial wrinkles and folds, structural volumization in the mid and lower face, contouring of cheekbones, chin and jawline,, nasal dorsum and tip shaping,, correction of facial asymmetry and age‑related volume loss
Release form: 1 × 1.0 mL pre‑filled sterile syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation), lidocaine hydrochloride, phosphate‑buffered saline solution.
Concentration of GC: 24 mg/mL
Lidocaine: 0.3%
Indications: deep dermal and subdermal facial augmentation,, restoration of facial architecture,, volumetric lifting, correction of severe tissue depression,, sculptural contouring requiring a high‑density filler.